	Capital Social Ordinario		Fecha
Acadia Pharmaceuticals	USD 168.71M	104K	2025-09
Akebia Therapeutics	USD 2K	0	2025-03
ALKERMES	USD 165.1M	49K	2025-09
Alnylam Pharmaceuticals	USD 132.38M	585K	2025-12
Amarin	USD 20.8M	28K	2025-09
ANI Pharmaceuticals	USD 21.73M	21.73M	2025-06
BioMarin Pharmaceutical	USD 192.1M	97K	2025-09
Coherus Biosciences	USD 12K	0	2025-03
Emergent BioSolutions	USD 100K	0	2023-06
Exact Sciences	USD 189.45M	232K	2025-09
Exelixis	USD 268.1M	2.03M	2025-09
Glaxosmithkline	GBP 4.03B	2.68B	2025-09
Heron Therapeutics	USD 1.52M	14K	2024-09
Ionis Pharmaceuticals	USD 161.14M	160.98M	2025-09
Ironwood Pharmaceuticals	USD 160K	0	2024-12
Lonza	CHF 72M	0	2024-12
Merck	USD 2.49B	15.79M	2025-09
Moderna	USD 391M	2M	2025-09
Myriad Genetics	USD 93.1M	0	2025-09
Nektar Therapeutics	USD 19K	0	2024-09
Neurocrine Biosciences	USD 100.1M	400K	2025-12
Pacira	USD 44.9M	44.85M	2025-06
Pfizer	USD 5.69B	1000K	2025-09
PTC Therapeutics	USD 79.93M	554K	2025-09
Sarepta Therapeutics	USD 104.77M	7.06M	2025-09
United Therapeutics	USD 42.9M	42.1M	2025-09
Vanda Pharmaceuticals	USD 58K	0	2024-12
Xoma	USD 87K	1000	2024-06

Emergent BioSolutions Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.